News May 23, 2024
Porton Pharma Solutions embark on the next frontier in Mengeš, Slovenia
On May 22, 2024 Opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients, small molecules, of Porton in Mengeš
News May 16, 2024
Porton at CPhI North America again
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
News Apr 30, 2024
Porton 2023 ESG Report
Porton has always adhered to the mission and original intention ofenabling the public's early access to good medicines and firmly practiced the concept
News Apr 19, 2024
Upcoming Porton Shows in Europe and the USA：Shaping Our Future Together
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
NewslettersMar 31, 2024
Porton Newsletter | Q1 2024 Recap
Porton PharmaTech (Slovenia)-B31 R&D Labs and Kilo lab Suites (non-GMP), expected to be completed in May 2024. New Facilities Will Be Ready in Porton USA / J-STAR Porton's Antibody and ADC GMP Pilot Manufactory Officially Operated
News Mar 28, 2024
Porton Makes Debut at DCAT Week 2024 to Jointly Promote Industry Development
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
News Mar 08, 2024
Join Our Founder and CEO @ DCAT Week
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
News Mar 02, 2024
Porton Pharma Solutions Joined the SBTi to Drive Climate Action
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
News Jan 05, 2024
Farewell to 2023, and WE are Sailing forward to 2024
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
